Le Week-End | Jewish General Hospital Foundation

“I am hopeful that together, we can improve the lives of cancer patients everywhere.”

— GREG LUGER TEAM BIKUS URACHUS

DOLLARS AT WORK

The funds raised from Le Week-end are allocated to four main areas of personalized cancer medicine. These include the detection, diagnosis, and targeting of cancer, as well as the support of patients.

DETECTION

Detecting cancers early leads to better outcomes. The JGH is working to develop new molecular imaging technology that can see tiny cancers. They are also making advances with biomarkers, which are indicators of cancer that can be detected through blood and serum tests.

DIAGNOSIS

The JGH is testing new equipment and procedures which help determine the specific genetic mutation of a patient. This information helps doctors and researchers recommend the optimal combination of drugs and other therapies to treat the patient.

TARGETING

Researchers, scientists, and doctors at the Segal Cancer Centre are developing ways to make surgery, radiation, and drug treatments more targeted to the cells with cancer. This approach will leave healthy tissue intact and minimize side effects. New treatments, such as immune therapy, will help lead to better survival rates.

SUPPORT

The Segal Cancer Centre is working on programs and strategies to help patients living with cancer, and their families, cope with the emotional and physical effects of cancer treatment. The award-winning survivorship, patient education, and psychosocial support programs help reduce stress and improve the overall patient experience .

“Giving back to the Segal Cancer Centre at the JGH, where people took such good care of me (and still do), is the least I can do.”

— LISA FERLAINO TEAM IMMUNE FORCE ONE